Full name
BIO-NOVUM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
20.59.Z - Manufacture of other chemical products not elsewhere classified
32.50.Z - Manufacture of medical and dental instruments and supplies
33.13.Z - Repair and maintenance of electronic and optical equipment
33.20.Z - Installation of industrial machinery and equipment and outfit
46.75.Z - Wholesale of chemical products
77.39.Z - Rental and leasing of other machinery, equipment and tangible goods not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,2 | 0,6 | 1,6 | 189,3 |
Gross profit (loss) | 1,2 | 0,6 | 1,5 | 157,6 |
EBITDA | 1,2 | 0,7 | 1,5 | 124 |
Short time liabilities | 1 | 0,6 | 1 | 69,9 |
Other operating costs | 0 | 0 | 0,6 | 2349,2 |
Income tax | ||||
Equity capital | 2,4 | 2,9 | 3,6 | 25,8 |
Operating profit (EBIT) | 1,2 | 0,7 | 1,5 | 122,2 |
Assets | 3,4 | 3,5 | 4,6 | 33,6 |
Net profit (loss) | 1 | 0,6 | 1,5 | 158,7 |
Cash | 1,6 | 1 | 1,2 | 23,1 |
Net income from sale | 5 | 6 | 9,9 | 64,6 |
Liabilities and provisions for liabilities | 1 | 0,6 | 1 | 69,9 |
Working assets | 3,4 | 3,5 | 4,5 | 30 |
Other income costs | 0 | 0,1 | 0,4 | 233,7 |
Depreciation | 0 | 0 | 0 | -∞ |
Basic operational activity income | ||||
% | % | % | p.p. | |
Profitability of capital | 42,9 | 20,8 | 42,7 | 21,9 |
Equity capital to total assets | 71,4 | 82,3 | 77,5 | -4,8 |
Gross profit margin | 23 | 9,9 | 15,5 | 5,6 |
EBITDA Margin | 23,6 | 11,1 | 15,1 | 4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 71 | 37 | 38 | 1 |
Current financial liquidity indicator | 3.4980881214141846 | 5.651094436645508 | 4.323086738586426 | -1,4 |
Net dept to EBITDA | -1.2986925840377808 | -1.371351957321167 | -0.8192290663719177 | 0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane